EdgarLookup

Jasper Therapeutics, Inc. — 10-Q Filings

18 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by Jasper Therapeutics, Inc. (JSPRW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Jasper Therapeutics, Inc. has filed 18 10-Q documents with the SEC since 2019. To view all SEC filings by Jasper Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 25-NSE 3 3/A 4 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP DEF 14A DEFA14A DRS EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-Q QUARTERLY REPORT 0001213900-25-107884 Nov 10, 2025 Sep 30, 2025
10-Q QUARTERLY REPORT 0001213900-25-075635 Aug 13, 2025 Jun 30, 2025
10-Q QUARTERLY REPORT 0001213900-25-042011 May 12, 2025 Mar 31, 2025
10-Q QUARTERLY REPORT 0001213900-24-095173 Nov 7, 2024 Sep 30, 2024
10-Q QUARTERLY REPORT 0001213900-24-067897 Aug 13, 2024 Jun 30, 2024
10-Q QUARTERLY REPORT 0001213900-24-042805 May 14, 2024 Mar 31, 2024
10-Q QUARTERLY REPORT 0001213900-23-084970 Nov 9, 2023 Sep 30, 2023
10-Q QUARTERLY REPORT 0001213900-23-066234 Aug 11, 2023 Jun 30, 2023
10-Q QUARTERLY REPORT 0001213900-23-039021 May 12, 2023 Mar 31, 2023
10-Q QUARTERLY REPORT 0001213900-22-071165 Nov 10, 2022 Sep 30, 2022
10-Q QUARTERLY REPORT 0001213900-22-047382 Aug 12, 2022 Jun 30, 2022
10-Q QUARTERLY REPORT 0001213900-22-025945 May 12, 2022 Mar 31, 2022
10-Q QUARTERLY REPORT 0001213900-21-058660 Nov 12, 2021 Sep 30, 2021
10-Q QUARTERLY REPORT 0001213900-21-043115 Aug 16, 2021 Jun 30, 2021
10-Q QUARTERLY REPORT 0001213900-21-028790 May 24, 2021 Mar 31, 2021
10-Q QUARTERLY REPORT 0001213900-20-036217 Nov 10, 2020 Sep 30, 2020
10-Q QUARTERLY REPORT 0001213900-20-022013 Aug 14, 2020 Jun 30, 2020
10-Q QUARTERLY REPORT 0001213900-20-012038 May 13, 2020 Mar 31, 2020